Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Portal Therapeutics Inc.
September 8, 2025
Portal Therapeutics Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of protoporphyria
Disease Area:
Rare Diseases
Source
Source
Scroll to Top
